Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1977; 70(Suppl 1): 4–8.
PMCID: PMC1542862

Clinical and experimental evidence on miconazole for the treatment of systemic mycoses: a review.


Intravenous treatment with miconazole brought about the recovery of 90% of patients with gastrointestinal or systemic candidosis. Miconazole given by the same route has also been found effective in the treatment of cryptococcosis, coccidioidomycosis, and paracoccidioidomycosis. Cryptococcal and coccidioidal meningitis have been cured by combined intravenous and intrathecal instillation, although treatment of aspergillosis has presented difficulty. Oral treatment was effective in curing dermatophyte skin infections and systemic mycoses caused by sensitive organisms such as paracoccidioides, blastomyces and histoplasma. The question of blood levels following oral and intravenous administration is discussed. Side effects of the drug were few, and included chills, dizziness, skin rash, itching and diarrhoea. Thus miconazole can safely be given to seriously ill patients. Its behaviour in the body is not influenced by renal insufficiency and no drug induced resistance has been reported.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Daneels R, Demeyere R, Eggers L, Lust P, van Landuyt H, Symoens J. Zur Behandlung systemischer Candidiasis mit Miconazol. Med Welt. 1974 Mar 8;25(10):428–429. [PubMed]
  • Fransen G, Van Camp K. Les candidoses rénales et urothéliales. Acta Urol Belg. 1974 Oct;42(4):452–471. [PubMed]
  • Hoeprich PD, Goldstein E. Miconazole therapy for coccidioidomycosis. JAMA. 1974 Nov 25;230(8):1153–1157. [PubMed]
  • Holt RJ. Recent developments in antimycotic chemotherapy. Infection. 1974;2(2):95–107. [PubMed]
  • Huijgens PC, Boeijinga JK, van der Meer J. Een mogelijk cardiotoxische reactie van miconazol-injectievloeistof. Ned Tijdschr Geneeskd. 1975 Oct 4;119(40):1549–1551. [PubMed]
  • Levine HB, Stevens DA, Cobb JM, Gebhardt AE. Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro. J Infect Dis. 1975 Oct;132(4):407–414. [PubMed]
  • Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery GS. Miconazole: a review of its antifungal activity and therapeutic efficacy. Drugs. 1975;9(6):406–423. [PubMed]
  • Stevens DA, Levine HB, Deresinski SC. Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med. 1976 Feb;60(2):191–202. [PubMed]
  • Van Cutsem JM, Thienpont D. Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. Chemotherapy. 1972;17(6):392–404. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press